Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer, Starboard Value
Former Pfizer executives not involved in Starboard's campaign against drugmaker
Pfizer's former CEO and Chair Ian Read and ex-CFO Frank D'Amelio said in a statement that they will not be involved with activist investor Starboard Value, which wants the U.S. drug giant to make changes to turn its performance around.
Pfizer’s Former CEO Won’t Be Involved in Starboard Value Effort
Former Pfizer Inc. executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist campaign against the drug company, according to statement released on their behalf late Wednesday.
Former Pfizer CEO, CFO step back from Starboard activist bid
CEO Ian Read and former CFO Frank D’Amelio said on Wednesday evening that they will step back from activist investor Starboard Value’s campaign for changes at the pharmaceutical giant. Read and D’Amelio said they were “fully supportive” of current Pfizer CEO Albert Bourla and the firm’s top management,
5h
on MSN
Why Pfizer Stock Popped Today
Pfizer ( PFE 3.46%) was a stock on the move Wednesday, and not because of any news generated by the healthcare company.
16h
What's Happening With Pfizer Stock?
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
1d
Pfizer goes from hunter to hunted as Starboard circles
With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.
2d
on MSN
Pfizer Stock Rises After It Gets an Activist. What Starboard’s Track Record With Pharma Tells Us.
Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...
2d
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback